SSC CHSL 2019 Phase I is scheduled to take place on October 12, 2020. One of the sections which will be there in the exam is English Language. It will have 25 questions of 50 maximum marks. You will get a total of 60 minutes for this test and there is no sectional timing in this test. The complete exam pattern is below:
|Sections/Subjects||Number of Questions each section||Maximum Marks||Time Duration|
|General Awareness||25||50||60 minutes (80 Minutes for PwD candidates)|
|English Language (Basic Knowledge)||25||50|
|Quantitative Aptitude (Basic Arithmetic Skill)||25||50|
In the English language section, generally questions from the below topics are asked:
- Reading Comprehension
- Cloze Test
- Para Jumbles
- Fill in the Blanks
- Multiple Meaning/Error Spotting
- Paragraph Completion
- One Word Substitution
- Active/Passive Voice
No sectional timing means that you can switch sections at your own pace while attempting the exam. So for example, if you answer Synonyms/Antonyms/Homonyms questions quickly, you can use the remaining time for other topics/sections. Vocabulary plays a very important role in answering the questions of this topic. To help you with your vocabulary, we are continuing an exercise where we analyze that day’s The Hindu Editorial and pick the difficult words. Next to the difficult word we put the contextual meaning of the word so that it would be easy for you to memorize it. Reading these analyses on a daily basis will definitely help you improve your word power. Let’s have a look at today’s Hindu Editorial which discusses COVID-19 vaccine.
|Difficult Word/Phrase||Contextual Meaning|
|prohibitively||in a way that forbids or prevents something|
|daunting||seeming difficult to deal with in anticipation|
|explicit||stated clearly and in detail, leaving no room for confusion or doubt|
|immunisation||A process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine.|
|vulnerable||susceptible to physical or emotional attack or harm|
|inoculated||treat (a person or animal) with a vaccine to produce immunity against a disease|
|laudable||deserving praise and commendation|
|paucity||the presence of something only in small or insufficient quantities or amounts|
|protracted||lasting for a long time or longer than expected or usual|
Weighing the costs: On COVID-19 vaccine
A prohibitively (in a way that forbids or prevents something) expensive vaccine, besides being unacceptable, will do little good
With over 6 million cases and the death toll from COVID-19 approaching 100,000, India is entering the first winter of the pandemic. Viral infections, particularly of the influenza variety, are also common at this time of the year and there may be new unknowns in the risks that lie ahead. However, another potential milestone approaches: the probable availability of a vaccine. Union Health Minister Harsh Vardhan, on multiple occasions has said that an India-made vaccine was likely to be available in “early 2021”. The government already has an expert committee on vaccine distribution. Their job is to decide who gets the vaccine first, how many will be eligible for the early doses, what the costs would be, and whether there should be a cost at all for the majority of Indians, who anyway were the hardest hit by the pandemic in the summer. Storage and supply of vaccines are also problems as daunting (seeming difficult to deal with in anticipation) as making one and pose complex challenges in India. The government is yet to make its policy on distribution explicit (stated clearly and in detail, leaving no room for confusion or doubt) but the current thinking appears to be that nobody would be denied a vaccine on the grounds of affordability. There is even discussion that a vaccine may be available via the national immunisation (a process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine) programme. This initiative currently offers at least nine vaccines for preventable diseases free for children and pregnant women. The pandemic’s global nature has meant that even the quest for a vaccine is international. The GAVI Covax alliance has emerged as the largest coordinator of vaccine development as well as distribution of a probable vaccine. Based on a combination of payments by 78 high-income countries and donations, the GAVI Covax aims to ensure that between 15-20% of every country’s population, or at least their most vulnerable (susceptible to physical or emotional attack or harm), are able to be inoculated (treat (a person or animal) with a vaccine to produce immunity against a disease) first.
In principle, these are laudable (deserving praise and commendation) aims and underline principles of equity. A paucity (the presence of something only in small or insufficient quantities or amounts) of testing facilities and equipment in March led to stringent restrictions on who could be tested. Though the tests were ‘free’, they were first available only in government facilities and this contributed to a significant pool of untested carriers and a rapid spread of the virus that was only marginally blunted (weakened) by the lockdown. Only after the number of labs expanded to both public and private labs, restrictions on who could get tested were removed and, a greater variety of tests became available that disease management improved even though testing — though not expensive — was also not free. It is to be anticipated that vaccine delivery will be a protracted (lasting for a long time or longer than expected or usual.) process and it will be a long time before the average citizen has access to it. There are at least three Indian companies testing their own vaccines, and so a prohibitively expensive vaccine, besides being unacceptable, is also unlikely.
- Download Practicemock App for Updated Current Affairs, Free Topic-Wise Quizzes and Free Mini Mocks
- PracticeMock recommends AffairsCloud Current Affairs 2020 PDF. Buy Now and get Rs. 30 off by using the coupon code "PRACTICEMOCK"